[Severe malaria: assessment of the treatment of anaemia and cerebral manifestations in a tropical intensive cares unit].
Gbadoé
A-D
AD
Lawson-Evi
K
K
Badayodi
A
A
Géraldo
A
A
Guédénon
J
J
Akpako
P
P
Agbéko
F
F
Atakouma
D-Y
DY
D000367:Age Factors; D000740:Anemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use; D000077549:Artemether; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D018592:Cross-Over Studies; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D015278:Intensive Care Units, Pediatric / Q000592:standards; D016779:Malaria, Cerebral / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D016778:Malaria, Falciparum / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D011787:Quality of Health Care; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use; D014037:Togo
D000962:Antimalarials; D037621:Artemisinins; D011803:Quinine; D000077549:Artemether